These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 8599249)

  • 1. Antisense GLUT1 RNA suppresses the transforming phenotypes of NIH 3T3 cells transformed by N-Ras.
    Choi JW; Yoon DJ; Lee HW; Han DP; Ahn YH
    Yonsei Med J; 1995 Dec; 36(6):480-6. PubMed ID: 8599249
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased cell-substrate adhesion accompanies conditional reversion to the normal phenotype in ras-oncogene-transformed NIH-3T3 cells.
    Shumaker DK; Sklar MD; Prochownik EV; Varani J
    Exp Cell Res; 1994 Oct; 214(2):440-6. PubMed ID: 7925639
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduced malignancy of ras-transformed NIH 3T3 cells expressing antisense osteopontin RNA.
    Behrend EI; Craig AM; Wilson SM; Denhardt DT; Chambers AF
    Cancer Res; 1994 Feb; 54(3):832-7. PubMed ID: 8306346
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fibroblasts transformed by different ras oncogenes show dissimilar patterns of protease gene expression and regulation.
    Zhang JY; Schultz RM
    Cancer Res; 1992 Dec; 52(23):6682-9. PubMed ID: 1423314
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thy-1 as a negative growth regulator in ras-transformed mouse fibroblasts.
    Sugimoto Y; Ikawa Y; Nakauchi H
    Cancer Res; 1991 Jan; 51(1):99-104. PubMed ID: 1670996
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibited neoplastic phenotype by the c-Ha-ras antisense RNA.
    Lu GR; Wu CJ; Ke Y; Xiong X; Li YJ; Liu JM; Xu Y; Xu W; Li JY; Deng GR
    Sci China B; 1991 Dec; 34(12):1485-91. PubMed ID: 1801843
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antisense DNA inhibition of tumor growth induced by c-Ha-ras oncogene in nude mice.
    Gray GD; Hernandez OM; Hebel D; Root M; Pow-Sang JM; Wickstrom E
    Cancer Res; 1993 Feb; 53(3):577-80. PubMed ID: 8425190
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Down-regulation of the insulin-like growth factor I receptor by antisense RNA can reverse the transformed phenotype of human cervical cancer cell lines.
    Nakamura K; Hongo A; Kodama J; Miyagi Y; Yoshinouchi M; Kudo T
    Cancer Res; 2000 Feb; 60(3):760-5. PubMed ID: 10676665
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reversal of transformed phenotypes by antisense fos.
    Bradley MO; Manam S; Kraynak AR; Nichols WW; Ledwith BJ
    Ann N Y Acad Sci; 1992 Oct; 660():124-35. PubMed ID: 1340116
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A ribozyme specifically suppresses transformation and tumorigenicity of Ha-ras-oncogene-transformed NIH/3T3 cell lines.
    Chang MY; Won SJ; Liu HS
    J Cancer Res Clin Oncol; 1997; 123(2):91-9. PubMed ID: 9030247
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suppression of facilitative glucose transporter 1 mRNA can suppress tumor growth.
    Noguchi Y; Saito A; Miyagi Y; Yamanaka S; Marat D; Doi C; Yoshikawa T; Tsuburaya A; Ito T; Satoh S
    Cancer Lett; 2000 Jun; 154(2):175-82. PubMed ID: 10806305
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ornithine decarboxylase induction in transformation by H-Ras and RhoA.
    Shantz LM; Pegg AE
    Cancer Res; 1998 Jul; 58(13):2748-53. PubMed ID: 9661886
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Osteopontin is required for full expression of the transformed phenotype by the ras oncogene.
    Wu Y; Denhardt DT; Rittling SR
    Br J Cancer; 2000 Jul; 83(2):156-63. PubMed ID: 10901364
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Defining the critical gene expression changes associated with expression and suppression of the tumorigenic and metastatic phenotype in Ha-ras-transformed cloned rat embryo fibroblast cells.
    Su ZZ; Austin VN; Zimmer SG; Fisher PB
    Oncogene; 1993 May; 8(5):1211-9. PubMed ID: 8479744
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Involvement of cAMP dependent protein kinase in the reversion of a NIH/3T3 cell line transformed by a ras oncogene (EJ-NIH/3T3)].
    Oda A
    Hokkaido Igaku Zasshi; 1988 Sep; 63(5):747-53. PubMed ID: 3071519
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulation of ras transformation affecting chromatin supraorganization as assessed by image analysis.
    Mello ML; Contente S; Vidal BC; Planding W; Schenck U
    Exp Cell Res; 1995 Oct; 220(2):374-82. PubMed ID: 7556446
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased glucose transport in ras-transformed fibroblasts: a possible role for N-glycosylation of GLUT1.
    Onetti R; Baulida J; Bassols A
    FEBS Lett; 1997 May; 407(3):267-70. PubMed ID: 9175865
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of recessive (mediator-) revertants from NIH 3T3 cells transformed with a c-H-ras oncogene.
    Yamada H; Omata-Yamada T; Lengyel P
    J Biol Chem; 1991 Feb; 266(6):4002-9. PubMed ID: 1995648
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential growth factor expression in transformed mouse NIH-3T3 cells.
    Ciardiello F; Valverius EM; Colucci-D'Amato GL; Kim N; Bassin RH; Salomon DS
    J Cell Biochem; 1990 Jan; 42(1):45-57. PubMed ID: 1967612
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Reversal of malignant cell phenotype of human pancreatic adenocarcinoma cell line by recombinant retroviral vector expressing antisense Ki-ras].
    Li H; Wang Z; Liu T
    Zhonghua Bing Li Xue Za Zhi; 1995 Oct; 24(5):288-91. PubMed ID: 8745475
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.